Sai Parenteral's Limited IPO
Price Band
₹372 - ₹392
Total Issue
₹409 Cr
Bid Dates
24 Mar - 27 Mar
Subscription
1.08x
Listing Price
₹400 (2.04%)
Valuation
Market Cap
₹1,731.83 Cr
P/E Ratio
72.19x
P/B Ratio
10.89x
Sai Parenteral's IPO Dates
Conflicting IPOs
IPOs with overlapping timeline
Business Overview
Sai Parenteral’s is a diversified pharmaceutical formulations company with capabilities across research, development and manufacturing. It operates in branded generic formulations and CDMO services, catering to both domestic and international markets. The Company’s portfolio spans multiple therapeutic areas including cardiovascular, neuropsychiatry, anti-diabetic, respiratory, antibiotics, gastroenterology, VMS, analgesics and dermatology, with dosage forms such as injectables, tablets, capsules, liquid orals and ointments. It has strong sterile manufacturing capabilities in injectables, particularly for critical care and antibiotics, delivered through formats such as dry powder injections, pre-filled syringes, ampoules and vials, supporting diverse patient needs.
Sai Parenteral's IPO Lot Size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | ₹14,896 |
| Retail (Max) | 13 | 494 | ₹1,93,648 |
| S-HNI (Min) | 14 | 532 | ₹2,08,544 |
| S-HNI (Max) | 67 | 2,546 | ₹9,98,032 |
| B-HNI (Min) | 68 | 2,584 | ₹10,12,928 |
Category Reservation
Sai Parenteral's IPO Size
Objects of Issue
- Capacity expansion & upgradation of manufacturing facilities
- Establishment of a new R&D centre
- Repayment / prepayment of certain outstanding borrowings
- Working capital requirements
- Repayment of bridge & term loans availed for investment in wholly owned subsidiary Sai Parenterals Pte ltd for acquisition of Noumed Pharmaceuticals Pty (Aus).
- General corporate purposes
Sai Parenteral's IPO Live Subscription
Updated as on 27-Mar-2026 19:00:00
| Category | Sub (x) | Offered | Bids |
|---|---|---|---|
| QIB | 1.73 | 20,85,659 | 36,10,266 |
| NII | 2.45 | 15,64,243 | 38,31,502 |
| bHNI | 3.56 | 10,42,829 | 37,07,318 |
| sHNI | 0.24 | 5,21,414 | 1,24,184 |
| Retail | 0.12 | 36,49,901 | 4,39,204 |
| Total | 1.08 | 72,99,803 | 78,80,972 |
Sai Parenteral's IPO Details Live GMP
| Date | GMP (₹) | Est. Price |
|---|---|---|
| 02 Apr | ₹0 (0%) | ₹392 |
| 01 Apr | ₹0 (0%) | ₹392 |
| 31 Mar | ₹0 (0%) | ₹392 |
| 30 Mar | ₹0 (0%) | ₹392 |
| 29 Mar | ₹0 (0%) | ₹392 |
| 28 Mar | ₹0 (0%) | ₹392 |
| 27 Mar | ₹0 (0%) | ₹392 |
| 26 Mar | ₹0 (0%) | ₹392 |
| 25 Mar | ₹0 (0%) | ₹392 |
| 24 Mar | ₹0 (0%) | ₹392 |
| 23 Mar | ₹0 (0%) | ₹392 |
| 22 Mar | ₹0 (0%) | ₹392 |
| 21 Mar | ₹0 (0%) | ₹392 |
| 20 Mar | ₹0 (0%) | ₹392 |
| 19 Mar | ₹0 (0%) | ₹392 |
| 18 Mar | ₹0 (0%) | ₹392 |
Sai Parenteral's IPO Peer Comparison
(Rs. in crores)
| Particulars | Sai Parenterals | Sai Life Sciences | Innova Captab | Senores Pharma | Gland Pharma |
|---|---|---|---|---|---|
| Revenue | 163.11 | 1,694.57 | 1,243.68 | 398.25 | 5,616.50 |
| PAT | 14.45 | 170.13 | 128.26 | 58.34 | 698.53 |
| EPS (₹) | 5.43 | 8.83 | 22.41 | 16.12 | 42.40 |
| NAV (₹) | 35.98 | 102.12 | 167.66 | 176.37 | 555.41 |
| RONW | 15.09% | 7.99% | 13.37% | 7.18% | 7.63% |
| EBITDA | 24.18% | 26.11% | 15.94% | 27.36% | 26.40% |
| PAT Mrgn | 8.88% | 10.04% | 10.31% | 14.65% | 12.44% |
| PE Ratio | 72.19 | 107.70 | 32.45 | 64.30 | 44.71 |
All information pertains to FY 2024-25.The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of February 03, 2026 for Peers
Sai Parenteral's IPO Financial Performance
(Rs. in crores)
| Particulars | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue | 86.92 | 163.11 | 153.76 | 96.80 |
| PAT | 7.76 | 14.45 | 8.42 | 4.38 |
| Net Worth | 209.37 | 95.78 | 76.40 | 31.49 |
| Borrowings | 76.07 | 93.95 | 118.79 | 68.55 |
| Assets | 376.24 | 272.39 | 268.10 | 133.96 |
| NAV (₹) | 56.73 | 35.98 | 57.67 | 44.03 |
| EPS (₹) | 2.82 | 5.43 | 10.54 | 6.16 |
Key Performance Indicators (KPIs)
EBITDA
24.18%
PAT
8.88%
RONW
15.09%
ROCE
28.92%
- All the data pertains to FY 2024-25.
- PE, PB, and market capitalization are calculated based on the Upper Price Band.
Promoter Holding
Promoter
61.23%
Public
38.77%
Management
Registrar & Lead Managers
Registrar
Bigshare Services
Lead Managers (1)
Company Details
Name: Sai Parenteral's Limited
Address: Plot No 39, 5th floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, K.V.Rangareddy, Seri Lingampally, Telangana, India, 500032
Number: +91 79979 91301
Email: cs@saiparenterals.com
Website: https://sww.saiparenterals.com/
Explore More IPOs
Discover other active and upcoming IPOs.
Live IPOs
View AllOpening Soon
View AllRecently Closed
View AllFrequently Asked Questions (FAQs)
What is Sai Parenteral's IPO?
When will Sai Parenteral's IPO open?
What is the GMP of Sai Parenteral's IPO?
What is the lot size of Sai Parenteral's IPO?
When is the allotment of Sai Parenteral's IPO?
What is the listing date of Sai Parenteral's IPO?
What is the subscription of Sai Parenteral's IPO?
What is the price band of Sai Parenteral's IPO?
How to check allotment status of Sai Parenteral's IPO?
How to apply Sai Parenteral's IPO in Zerodha?
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
How to apply Sai Parenteral's IPO in Groww?
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
How to apply Sai Parenteral's IPO using ASBA?
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Sai Parenteral's IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
Delete Comment?
Are you sure you want to delete this comment? This action cannot be undone.
Discussion
Join the discussion!
Log In to CommentNo comments yet. Be the first to share your thoughts!